Europe Archives - Page 32 of 93 - Journal for Clinical Studies

Current Edition

Europe

Novartis announces positive results from two Entresto trials

by Anna Smith Novartis has announced results from two new clinical trials evaluating improvement in heart structure and function and long-term safety of Entresto...

5 September 2019 Europe | news

Continue Reading →

Europe

NICE nod for Novartis’ Luxturna

by Anna Smith The National Institute for Health and Care Excellence (NICE) has recommended the use of Luxturna (voretigene neparvovec) on the NHS, Novartis has ann...

5 September 2019 Europe | news

Continue Reading →

Europe

Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure

AstraZeneca today announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite endpoint ...

29 August 2019 Europe | news | Regional News

Continue Reading →

Europe

AstraZeneca’s Breztri scores in COPD trial, amping its case for triple-combo battle against GSK

Could "orphan drug" status for Fasenra and a Breztri trial win give AstraZeneca a leg up in its battle against GlaxoSmithKline? (AstraZeneca) AstraZeneca and Gla...

29 August 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

AstraZeneca’s Imfinzi-tremelimumab duo flops another late-stage lung cancer trial

AstraZeneca is still testing Imfinzi on its own and in tandem with chemo in stage 4 lung cancer. (AstraZeneca) AstraZeneca has had high hopes for an immuno-oncol...

22 August 2019 Europe | news | Regional News

Continue Reading →

Europe

Medicines Co. awaits its date with destiny

Investors in The Medicines Company have Sept. 2 circled in red on their calendars. That's the day the company plans to report the first pivotal results from late-...

22 August 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Study finds lack of racial diversity in cancer drug clinical trials

New research published in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study - conducted by researchers fro...

22 August 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Regeneron’s Eylea snags prefilled syringe approval as Novartis rival looms

Regeneron's Eylea scored a nod for a prefilled injector application to treat four retinal conditions. (Regeneron) Eye med Eylea has been a blockbuster sales forc...

15 August 2019 Europe | news | Regional News

Continue Reading →

Europe

AZ, Merck’s latest Lynparza combo win could widen its ovarian cancer reach

The PARP inhibitor Lynparza is in a three-way market battle with GSK's Zejula and Clovis' Rubraca. (AstraZeneca) In the red-hot market for PARP inhibitors, Astra...

15 August 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Study success strengthens case for Lynparza in ovarian cancer

(Credit: AstraZeneca ) Adding AstraZeneca's Lynparza to Roche's older cancer drug Avastin helped women with advanced ovarian cancer live longer without their tum...

15 August 2019 Europe | news | North America | Regional News

Continue Reading →